# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | Guanosine monophosphate | GMP | Ki | = | 4.5 | uM | ALA2422797 | 5.35 | nM | |||
2. | Guanosine monophosphate | GMP | Ki | = | 120 | uM | ALA2422793 | nM | ||||
3. | Guanosine monophosphate | GMP | Ki | = | 526 | uM | ALA2422792 | nM | ||||
4. | Guanosine monophosphate | GMP | INH | 0 | ALA3390549 | Not Active | % | Homo sapiens | ||||
5. | Guanosine monophosphate | GMP | INH | 0 | ALA3381414 | Active | % | |||||
6. | Guanosine monophosphate | GMP | inhibition | = | 0.05 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
7. | Guanosine monophosphate | GMP | Inhibition | = | 1.9 | % | ALA4495582 | % | Severe acute respiratory syndrome coronavirus 2 | |||
8. | Guanosine monophosphate | GMP | Kd | = | 67 | uM | ALA4476968 | 4.17 | nM | Homo sapiens | ||
9. | Guanosine monophosphate | GMP | inhibition | = | 0.05 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
10. | Guanosine monophosphate | GMP | Ki | = | 526 | uM | ALA3579428 | nM | ||||
11. | Guanosine monophosphate | GMP | Ki | = | 5.8 | uM | ALA3579427 | 5.24 | nM | Homo sapiens | ||
12. | Guanosine monophosphate | GMP | Ki | = | 20 | uM | ALA3579426 | 4.70 | nM | |||
13. | Guanosine monophosphate | GMP | Ki | = | 1.5 | 10'-3M | ALA3253158 | nM | Homo sapiens | |||
14. | Guanosine monophosphate | GMP | INH | = | 16 | % | ALA3253157 | % | Homo sapiens | |||
15. | Guanosine monophosphate | GMP | Activity | = | 4 | % | ALA3253154 | % | Homo sapiens | |||
16. | Guanosine monophosphate | GMP | Ratio Ki | = | 0.6 | ALA1035273 | ||||||
17. | Guanosine monophosphate | GMP | Ki | = | 5.8 | uM | ALA1035272 | 5.24 | nM | Homo sapiens | ||
18. | Guanosine monophosphate | GMP | Ki | = | 10 | uM | ALA1035271 | 5.00 | nM | |||
19. | Guanosine monophosphate | GMP | Km | = | 18 | uM | ALA686069 | nM | Homo sapiens |